Logo image of VENU

VENU HOLDING CORP (VENU) Stock Fundamental Analysis

NYSEARCA:VENU - US92333E1047 - Common Stock

11.76 USD
-0.22 (-1.84%)
Last: 9/5/2025, 8:04:00 PM
Fundamental Rating

2

Taking everything into account, VENU scores 2 out of 10 in our fundamental rating. VENU was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. VENU scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. VENU is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

VENU had negative earnings in the past year.
In the past year VENU has reported a negative cash flow from operations.
VENU Yearly Net Income VS EBIT VS OCF VS FCFVENU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

VENU has a Return On Assets of -15.41%. This is amonst the worse of the industry: VENU underperforms 88.06% of its industry peers.
Looking at the Return On Equity, with a value of -41.86%, VENU is doing worse than 64.18% of the companies in the same industry.
Industry RankSector Rank
ROA -15.41%
ROE -41.86%
ROIC N/A
ROA(3y)-14.25%
ROA(5y)N/A
ROE(3y)-36.43%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VENU Yearly ROA, ROE, ROICVENU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

VENU has a Gross Margin (46.51%) which is comparable to the rest of the industry.
VENU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VENU Yearly Profit, Operating, Gross MarginsVENU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -50 -100 -150

More info and screens

4

2. Health

2.1 Basic Checks

VENU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VENU has more shares outstanding
The debt/assets ratio for VENU is higher compared to a year ago.
VENU Yearly Shares OutstandingVENU Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
VENU Yearly Total Debt VS Total AssetsVENU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M

2.2 Solvency

VENU has an Altman-Z score of 1.39. This is a bad value and indicates that VENU is not financially healthy and even has some risk of bankruptcy.
VENU has a Altman-Z score of 1.39. This is comparable to the rest of the industry: VENU outperforms 43.28% of its industry peers.
VENU has a Debt/Equity ratio of 0.69. This is a neutral value indicating VENU is somewhat dependend on debt financing.
VENU's Debt to Equity ratio of 0.69 is fine compared to the rest of the industry. VENU outperforms 64.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z 1.39
ROIC/WACCN/A
WACC8.76%
VENU Yearly LT Debt VS Equity VS FCFVENU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 2.72 indicates that VENU has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.72, VENU belongs to the top of the industry, outperforming 94.03% of the companies in the same industry.
VENU has a Quick Ratio of 2.70. This indicates that VENU is financially healthy and has no problem in meeting its short term obligations.
VENU has a Quick ratio of 2.70. This is amongst the best in the industry. VENU outperforms 94.78% of its industry peers.
Industry RankSector Rank
Current Ratio 2.72
Quick Ratio 2.7
VENU Yearly Current Assets VS Current LiabilitesVENU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

VENU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -186.29%.
The Revenue has grown by 41.57% in the past year. This is a very strong growth!
EPS 1Y (TTM)-186.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.71%
Revenue 1Y (TTM)41.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.18%

3.2 Future

VENU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.81% yearly.
VENU is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 111.67% yearly.
EPS Next Y-23.96%
EPS Next 2Y64.25%
EPS Next 3Y26.81%
EPS Next 5YN/A
Revenue Next Year80.67%
Revenue Next 2Y208.3%
Revenue Next 3Y111.67%
Revenue Next 5YN/A

3.3 Evolution

VENU Yearly Revenue VS EstimatesVENU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 50M 100M 150M
VENU Yearly EPS VS EstimatesVENU Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VENU. In the last year negative earnings were reported.
VENU is valuated quite expensively with a Price/Forward Earnings ratio of 25.81.
Compared to the rest of the industry, the Price/Forward Earnings ratio of VENU is on the same level as its industry peers.
VENU's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.69.
Industry RankSector Rank
PE N/A
Fwd PE 25.81
VENU Price Earnings VS Forward Price EarningsVENU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VENU Per share dataVENU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

VENU's earnings are expected to grow with 26.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.25%
EPS Next 3Y26.81%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VENU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VENU HOLDING CORP

NYSEARCA:VENU (9/5/2025, 8:04:00 PM)

11.76

-0.22 (-1.84%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)N/A N/A
Inst Owners3.14%
Inst Owner Change60.48%
Ins Owners27.17%
Ins Owner Change-0.83%
Market Cap474.05M
Analysts82.22
Price Target15.13 (28.66%)
Short Float %1.28%
Short Ratio2.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.71%
PT rev (3m)7.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-276.3%
EPS NY rev (3m)-276.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.44%
Revenue NY rev (3m)-10.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.81
P/S 27.25
P/FCF N/A
P/OCF N/A
P/B 6.05
P/tB 6.06
EV/EBITDA N/A
EPS(TTM)-0.86
EYN/A
EPS(NY)0.46
Fwd EY3.87%
FCF(TTM)-2.19
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.43
BVpS1.94
TBVpS1.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.41%
ROE -41.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.51%
FCFM N/A
ROA(3y)-14.25%
ROA(5y)N/A
ROE(3y)-36.43%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1934.1%
Cap/Sales 492.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.72
Quick Ratio 2.7
Altman-Z 1.39
F-Score2
WACC8.76%
ROIC/WACCN/A
Cap/Depr(3y)1444.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)249.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-186.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.71%
EPS Next Y-23.96%
EPS Next 2Y64.25%
EPS Next 3Y26.81%
EPS Next 5YN/A
Revenue 1Y (TTM)41.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-11.18%
Revenue Next Year80.67%
Revenue Next 2Y208.3%
Revenue Next 3Y111.67%
Revenue Next 5YN/A
EBIT growth 1Y-145.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year38.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-90.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y177.06%
OCF growth 3YN/A
OCF growth 5YN/A